Advirna

Advirna is presenting at 2023 OTS meeting in Barcelona

Advirna provides services in designing chemically stabilized siRNA conjugates for theraputic development and in vivo target validation.

Ligand Conjugation – Expanding the Reach of Oligonucleotide Therapeutics - Oligonucleotide Therapeutics Society Oligonucleotide therapies possess enormous potential as healing, life-changing, and cancer-curing drugs. However, there are many barriers to utilizing oligonucleotides to treat disease. Discovering or creating effective delivery methods for each target cell or tissue type solves many of these. There...

Indeed... Just another fact which is not discuses broadly...

Part 1: Defying all predictions, Africa is the global COVID-19 ‘cold spot’. How come health officials and the media are not honestly exploring why? | Genetic Literacy Project The first confirmed COVID-19 case in Africa was on February 14, 2020 in Egypt. The first in sub-Saharan Africa appeared in Nigeria soon after.